Mode
Text Size
Log in / Sign up

Patient Questions

Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.

Gastroenterology

Are there new immunomodulation strategies to treat liver fibrosis?

Yes, new immunomodulation strategies for liver fibrosis focus on reprogramming macrophages, targeting specific immune subsets, and using metabolic therapies like GLP-1 analogues…

Gastroenterology

Is diarrhea in the last few weeks a predictor of slower reaction times?

Research shows that diarrhea in the last few weeks is linked to slower visual reaction times in young children, likely due to nutrient depletion and immune stress.

Gastroenterology

What are the gut microbiome differences between diarrheal and non-diarrheal samples?

Diarrheal gut samples show lower bacterial diversity and higher levels of harmful bacteria like E. coli, while healthy samples have more beneficial bacteria like Faecalibacterium.

Gastroenterology

Can BRAFV600E mutation testing help diagnose high-suspicion thyroid nodules with non-malignant cytology?

BRAFV600E mutation testing can help identify hidden cancers in thyroid nodules that look dangerous on ultrasound but test benign on standard cell samples.

Gastroenterology

Can a comprehensive geriatric assessment help older adults with gastrointestinal malignancies live longer?

Comprehensive geriatric assessment helps older adults with gastrointestinal cancers live longer by identifying frailty and changing treatment plans to avoid complications.

Gastroenterology

Does having Lynch Syndrome mean I will definitely get colon cancer?

Having Lynch Syndrome greatly increases your risk of colon cancer, but it does not mean you will definitely get it. Regular colonoscopies can lower the chance of dying from the…

Gastroenterology

How common is cognitive dysfunction in children who have had a liver transplant?

About 24% of children who have a liver transplant experience cognitive dysfunction, with higher rates in those transplanted before age 1 (39.4%) and in Asia (30.6%).

Gastroenterology

Do people with inflammatory bowel disease have higher risks of kidney stones?

People with inflammatory bowel disease, especially Crohn's disease, have a higher risk of kidney stones due to malabsorption and chronic inflammation.

Gastroenterology

What evidence exists for liver cancer alongside lung, breast, and kidney cancer?

Research shows liver cancer detection using liquid biopsies has high accuracy similar to lung, breast, and kidney cancers, while survival rates for liver cancer have improved…

Gastroenterology

What are the findings on chronic pancreatitis risk in the UK Biobank?

UK Biobank data shows metabolic syndrome, sedentary lifestyles, smoking, and alcohol use increase chronic pancreatitis risk, while a Mediterranean diet lowers it.

Gastroenterology

Does activating the aryl hydrocarbon receptor cause liver damage?

Activating the aryl hydrocarbon receptor can cause liver damage or protect it depending on the specific signals and context, acting as a double-edged sword in liver health.

Gastroenterology

Does mitochondrial dysfunction play a role in liver injury?

Yes, mitochondrial dysfunction is a key driver of liver injury, contributing to cell death and disease progression in conditions like fatty liver and alcohol-associated liver…

Gastroenterology

Does having metabolic syndrome increase my risk of chronic pancreatitis?

Yes, having metabolic syndrome significantly increases your risk of developing chronic pancreatitis, with studies showing the risk more than doubles.

Gastroenterology

Does eating ultra-processed food make my nonalcoholic fatty liver disease worse?

Eating ultra-processed foods is linked to obesity and metabolic disease, which are major drivers of nonalcoholic fatty liver disease (NAFLD).

Gastroenterology

What are the current management options for nonalcoholic fatty liver disease?

Current management for nonalcoholic fatty liver disease focuses on lifestyle changes like weight loss and exercise, while new drug options are being studied but none are yet…

Gastroenterology

Does exercise training help reduce liver fat in people with nonalcoholic fatty liver disease?

Yes, exercise training reduces liver fat in people with NAFLD, with high-intensity interval training and aerobic exercise showing the strongest effects.

Gastroenterology

How does exercise training improve metabolic markers for nonalcoholic fatty liver disease?

Exercise training reduces liver fat, lowers blood sugar and insulin, and improves mitochondrial function in people with nonalcoholic fatty liver disease.

Gastroenterology

Does having HBV make surgery more likely for unresectable hepatocellular carcinoma?

Having hepatitis B virus (HBV) infection is linked to a higher chance of surgical conversion for patients with unresectable hepatocellular carcinoma treated with triple therapy.

Gastroenterology

Can triple therapy help patients with unresectable hepatocellular carcinoma live longer?

Yes, triple therapy (TACE plus targeted drugs and immunotherapy) can help patients with unresectable hepatocellular carcinoma live longer, with studies showing improved overall…

Gastroenterology

Does adding camrelizumab improve outcomes for unresectable hepatocellular carcinoma patients?

Adding camrelizumab to standard treatments like TACE and targeted drugs significantly improves tumor response, disease control, and survival times for patients with unresectable…

Gastroenterology

What are the management options for NAFLD and NASH without trial data?

Lifestyle changes (diet, exercise, weight loss) are the mainstay of NAFLD/NASH management; vitamin E and some medications may help, but always consult your doctor.

Gastroenterology

Can gene modulation help treat liver fibrosis and MASH?

Yes, gene modulation is a promising experimental approach for liver fibrosis and MASH, with several strategies showing preclinical success, though human treatments are not yet…

Gastroenterology

How do machine learning models help diagnose liver fibrosis?

Machine learning models analyze patient data to predict liver fibrosis with moderate accuracy, often outperforming traditional tests like FIB-4, but they are not yet standard in…

Gastroenterology

What are the new antifibrotic therapies for liver fibrosis?

New antifibrotic therapies focus on reprogramming immune cells like macrophages and using metabolic drugs that reduce liver fat, rather than just targeting scar tissue directly.

How this works

We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.

This is not medical advice. Always speak with your own doctor before making decisions about your health.